These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
385 related items for PubMed ID: 776850
1. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance. Waters MF, Pearson JM, Rees RJ. Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850 [No Abstract] [Full Text] [Related]
2. Does dapsone resistance really matter in the MDT era? Ji B. Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322 [No Abstract] [Full Text] [Related]
3. Dapsone drug resistance in the MDT era. Roche PW, Neupane KD, Failbus SS, Butlin CR. Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097 [No Abstract] [Full Text] [Related]
4. Dormancy, drug resistance or dependency; some thoughts to ponder. Shetty VP, Mistry NF, Uplekar MW, Antia NH, Pai VV, Ganapati R. Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116 [No Abstract] [Full Text] [Related]
5. Concepts behind the development of multiple drug therapy regimens in leprosy. Waters MF. Lepr Rev; 1986 Dec; 57 Suppl 1():61-7. PubMed ID: 3295437 [No Abstract] [Full Text] [Related]
6. Drug resistance in leprosy: lessons from past and future perspective. Gupta UD, Katoch VM. Indian J Lepr; 1999 Dec; 71(4):451-63. PubMed ID: 10804973 [Abstract] [Full Text] [Related]
8. Concepts behind the development of multiple drug therapy regimens in leprosy. Waters MF. Ethiop Med J; 1986 Dec; 24 Suppl 1():61-7. PubMed ID: 3301333 [No Abstract] [Full Text] [Related]
9. Primary dapsone resistant Mycobacterium leprae in a non endemic country. Jamil A, Noor NM, Osman AS, Baseri MM, Muthupalaniappen L. Indian J Dermatol Venereol Leprol; 2013 Dec; 79(4):527-9. PubMed ID: 23760326 [No Abstract] [Full Text] [Related]
11. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy. Cambau E, Carthagena L, Chauffour A, Ji B, Jarlier V. Clin Infect Dis; 2006 Jan 15; 42(2):238-41. PubMed ID: 16355335 [Abstract] [Full Text] [Related]
18. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India. Ebenezer GJ, Norman G, Joseph GA, Daniel S, Job CK. Indian J Lepr; 2002 Jan 08; 74(4):301-12. PubMed ID: 12624978 [Abstract] [Full Text] [Related]
19. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations]. Sansarricq H. Acta Leprol; 1986 Jan 08; 4(3):355-62. PubMed ID: 3551474 [No Abstract] [Full Text] [Related]
20. The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea. Lee SB, Kim SK, Kang TJ, Chae GT, Chun JH, Shin HK, Kim JP, Ko YH, Kim NH. Ann Trop Med Parasitol; 2001 Jun 08; 95(4):429-32. PubMed ID: 11454253 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]